Cornerstone Financial Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-40,615
Closed -$2.55M 142
2016
Q4
$2.55M Sell
40,615
-19,747
-33% -$1.21M 0.81% 35
2016
Q3
$3.81M Sell
60,362
-96
-0.2% -$6.21K 1.33% 19
2016
Q2
$3.75M Buy
60,458
+5,693
+10% +$347K 1.33% 18
2016
Q1
$3.13M Sell
54,765
-4,998
-8% -$279K 1.21% 22
2015
Q4
$3.53M Buy
+59,763
New +$3.44M 1.31% 14

Other funds holding ABBV

Cornerstone Financial Partners's ABBV Position: Q1 2017 in Review

Cornerstone Financial Partners sold out of AbbVie (ABBV) in Q1 2017, closing a stake of 40,615 shares — an estimated $2.55M sold.

Cornerstone Financial Partners first reported a position in ABBV in Q4 2015 and held it in 5 quarters. The position peaked at $3.81M in Q3 2016. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Cornerstone Financial Partners reported no remaining AbbVie position as of Q1 2017 after selling out during the quarter.
  • Cornerstone Financial Partners sold 40,615 AbbVie shares in Q1 2017, an estimated $2.55M.
  • Cornerstone Financial Partners first reported a position in AbbVie in Q4 2015 and held it in 5 quarters.
  • Cornerstone Financial Partners's AbbVie position peaked at $3.81M in Q3 2016.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Cornerstone Financial Partners's 13F filing for Q1 2017, filed 17 Apr 2017.